Hantavirus pulmonary syndrome

Virus Research

Volumn 162, Issue 1-2, 2011, Pages 138-147

  MacNeil, Adam ^a   Nichol, Stuart T ^a   Spiropoulou, Christina F ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

Hantavirus pulmonary syndrome; New World hantaviruses; Vascular permeability; Zoonotic diseases

Indexed keywords

BETA INTERFERON; DIHYDROLIPOAMIDE DEHYDROGENASE; RIBAVIRIN; STAT1 PROTEIN; STAT2 PROTEIN;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ANDES VIRUS; BLOOD VESSEL PERMEABILITY; BUNYAVIRUS; CARDIOGENIC SHOCK; CELL MEMBRANE PERMEABILITY; DISEASE SEVERITY; DRUG EFFECT; ENDOTHELIUM CELL; FATALITY; HANTAVIRUS; HANTAVIRUS PULMONARY SYNDROME; HUMAN; IMMUNE RESPONSE; IMMUNE STATUS; IN VITRO STUDY; INNATE IMMUNITY; INTERNALIZATION; LIFE CYCLE; LUNG EDEMA; MEDICAL CARE; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; RNA BINDING; SIN NOMBRE VIRUS; THROMBOCYTOPENIA; TREATMENT OUTCOME; VIRAL CLEARANCE; VIRUS; VIRUS ATTACHMENT; VIRUS CHARACTERIZATION; VIRUS GENOME; VIRUS MORPHOLOGY; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

ANIMALS; ANTIVIRAL AGENTS; CRICETINAE; EUROPE; GENOME, VIRAL; HANTAAN VIRUS; HANTAVIRUS; HANTAVIRUS PULMONARY SYNDROME; HEMORRHAGIC FEVER WITH RENAL SYNDROME; HUMANS; LUNG; NORTH AMERICA; PHYLOGEOGRAPHY; RESPIRATORY INSUFFICIENCY; RIBAVIRIN; SHOCK, CARDIOGENIC; SIN NOMBRE VIRUS; SOUTH AMERICA;

ANDES VIRUS; BUNYAVIRIDAE; HANTAAN VIRUS; HANTAVIRUS; SIN NOMBRE VIRUS;

EID: 81555228714     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2011.09.017     Document Type: Review

References (171)

1. Abel Borges A., Figueiredo L.T. Mechanisms of shock in hantavirus pulmonary syndrome. Current Opinion in Infectious Diseases 2008, 21:293-297.
2. Alff P.J., Gavrilovskaya I.N., Gorbunova E., Endriss K., Chong Y., Geimonen E., Sen N., Reich N.C., Mackow E.R. The pathogenic NY-1 hantavirus G1 cytoplasmic tail inhibits RIG-I- and TBK-1-directed interferon responses. Journal of Virology 2006, 80:9676-9686.
3. Alff P.J., Sen N., Gorbunova E., Gavrilovskaya I.N., Mackow E.R. The NY-1 hantavirus Gn cytoplasmic tail coprecipitates TRAF3 and inhibits cellular interferon responses by disrupting TBK1-TRAF3 complex formation. Journal of Virology 2008, 82:9115-9122.
4. Armien B., Pascale J.M., Bayard V., Munoz C., Mosca I., Guerrero G., Armien A., Quiroz E., Castillo Z., Zaldivar Y., et al. High seroprevalence of hantavirus infection on the Azuero peninsula of Panama. American Journal of Tropical Medicine and Hygiene 2004, 70:682-687.
5. Bharadwaj M., Nofchissey R., Goade D., Koster F., Hjelle B. Humoral immune responses in the hantavirus cardiopulmonary syndrome. The Journal of Infectious Diseases 2000, 182:43-48.
6. Borges A.A., Campos G.M., Moreli M.L., Souza R.L., Aquino V.H., Saggioro F.P., Figueiredo L.T. Hantavirus cardiopulmonary syndrome: immune response and pathogenesis. Microbes and Infection/Institut Pasteur 2006, 8:2324-2330.
7. Boroja M., Barrie J.R., Raymond G.S. Radiographic findings in 20 patients with Hantavirus pulmonary syndrome correlated with clinical outcome. American Journal of Roentgenology 2002, 178:159-163.
8. Campos G.M., Moro de Sousa R.L., Badra S.J., Pane C., Gomes U.A., Figueiredo L.T. Serological survey of hantavirus in Jardinopolis County, Brazil. Journal of Medical Virology 2003, 71:417-422.
9. Castillo C., Naranjo J., Sepulveda A., Ossa G., Levy H. Hantavirus pulmonary syndrome due to Andes virus in Temuco Chile: clinical experience with 16 adults. Chest 2001, 120:548-554.
10. Chapman L.E., Mertz G.J., Peters C.J., Jolson H.M., Khan A.S., Ksiazek T.G., Koster F.T., Baum K.F., Rollin P.E., Pavia A.T., et al. Intravenous ribavirin for hantavirus pulmonary syndrome: safety and tolerance during 1 year of open-label experience. Ribavirin Study Group. Antiviral Therapy 1999, 4:211-219.
11. Cheng E., Haque A., Rimmer M.A., Hussein I.T., Sheema S., Little A., Mir M.A. Characterization of the interaction between hantavirus nucleocapsid protein (N) and ribosomal protein S19 (RPS19). Journal of Biological Chemistry 2011, 286:11814-11824.
12. Childs J.E., Ksiazek T.G., Spiropoulou C.F., Krebs J.W., Morzunov S., Maupin G.O., Gage K.L., Rollin P.E., Sarisky J., Enscore R.E., et al. Serologic and genetic identification of Peromyscus maniculatus as the primary rodent reservoir for a new hantavirus in the southwestern United States. The Journal of Infectious Diseases 1994, 169:1271-1280.
13. Cifuentes-Munoz N., Barriga G.P., Valenzuela P.D., Tischler N.D. Aromatic and polar residues spanning the candidate fusion peptide of the Andes virus Gc protein are essential for membrane fusion and infection. Journal of General Virology 2011, 92:552-563.
14. Drebot M.A., Artsob H., Werker D. Hantavirus pulmonary syndrome in Canada, 1989-1999. Canada Communicable Disease Report 2000, 26:65-69.
15. Duchin J.S., Koster F.T., Peters C.J., Simpson G.L., Tempest B., Zaki S.R., Ksiazek T.G., Rollin P.E., Nichol S., Umland E.T., et al. Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. The Hantavirus Study Group. The New England Journal of Medicine 1994, 330:949-955.
16. Ennis F.A., Cruz J., Spiropoulou C.F., Waite D., Peters C.J., Nichol S.T., Kariwa H., Koster F.T. Hantavirus pulmonary syndrome: CD8+ and CD4+ cytotoxic T lymphocytes to epitopes on Sin Nombre virus nucleocapsid protein isolated during acute illness. Virology 1997, 238:380-390.
17. Espinoza R., Vial P., Noriega L.M., Johnson A., Nichol S.T., Rollin P.E., Wells R., Zaki S., Reynolds E., Ksiazek T.G. Hantavirus pulmonary syndrome in a Chilean patient with recent travel in Bolivia. Emerging Infectious Diseases 1998, 4:93-95.
18. Ferrer J.F., Jonsson C.B., Esteban E., Galligan D., Basombrio M.A., Peralta-Ramos M., Bharadwaj M., Torrez-Martinez N., Callahan J., Segovia A., et al. High prevalence of hantavirus infection in Indian communities of the Paraguayan and Argentinean Gran Chaco. American Journal of Tropical Medicine and Hygiene 1998, 59:438-444.
19. Ferres M., Vial P., Marco C., Yanez L., Godoy P., Castillo C., Hjelle B., Delgado I., Lee S.J., Mertz G.J. Prospective evaluation of household contacts of persons with hantavirus cardiopulmonary syndrome in chile. The Journal of Infectious Diseases 2007, 195:1563-1571.
20. Figueiredo L.T., Moreli M.L., de-Sousa R.L., Borges A.A., de-Figueiredo G.G., Machado A.M., Bisordi I., Nagasse-Sugahara T.K., Suzuki A., Pereira L.E., et al. Hantavirus pulmonary syndrome, central plateau, southeastern, and southern Brazil. Emerging Infectious Diseases 2009, 15:561-567.
21. Frampton J.W., Lanser S., Nichols C.R. Sin Nombre virus infection in 1959. The Lancet 1995, 346:781-782.
22. Fritz C.L., Fulhorst C.F., Enge B., Winthrop K.L., Glaser C.A., Vugia D.J. Exposure to rodents and rodent-borne viruses among persons with elevated occupational risk. Journal of Occupational and Environmental Medicine/American College of Occupational and Environmental Medicine 2002, 44:962-967.
23. Fulhorst C.F., Milazzo M.L., Armstrong L.R., Childs J.E., Rollin P.E., Khabbaz R., Peters C.J., Ksiazek T.G. Hantavirus and arenavirus antibodies in persons with occupational rodent exposure. Emerging Infectious Diseases 2007, 13:532-538.
24. Garcia-Sastre A., Biron C.A. Type 1 interferons and the virus-host relationship: a lesson in detente. Science 2006, 312:879-882.
25. Garcin D., Lezzi M., Dobbs M., Elliott R.M., Schmaljohn C., Kang C.Y., Kolakofsky D. The 5' ends of Hantaan virus (Bunyaviridae) RNAs suggest a prime-and-realign mechanism for the initiation of RNA synthesis. Journal of Virology 1995, 69:5754-5762.
26. Gavard J., Gutkind J.S. VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. Nature Cell Biology 2006, 8:1223-1234.
27. Gavrilovskaya I.N., Brown E.J., Ginsberg M.H., Mackow E.R. Cellular entry of hantaviruses which cause hemorrhagic fever with renal syndrome is mediated by beta3 integrins. Journal of Virology 1999, 73:3951-3959.
28. Gavrilovskaya I.N., Gorbunova E.E., Mackow E.R. Pathogenic hantaviruses direct the adherence of quiescent platelets to infected endothelial cells. Journal of Virology 2010, 84:4832-4839.
29. Gavrilovskaya I.N., Gorbunova E.E., Mackow N.A., Mackow E.R. Hantaviruses direct endothelial cell permeability by sensitizing cells to the vascular permeability factor VEGF, while angiopoietin 1 and sphingosine 1-phosphate inhibit hantavirus-directed permeability,. Journal of Virology 2008, 82:5797-5806.
30. Gavrilovskaya I.N, Shepley M., Shaw R., Ginsberg M.H., Mackow E.R. beta3 Integrins mediate the cellular entry of hantaviruses that cause respiratory failure. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:7074-7079.
31. Geimonen E., LaMonica R., Springer K., Farooqui Y., Gavrilovskaya I.N., Mackow E.R. Hantavirus pulmonary syndrome-associated hantaviruses contain conserved and functional ITAM signaling elements. Journal of Virology 2003, 77:1638-1643.
32. Geimonen E., Neff S., Raymond T., Kocer S.S., Gavrilovskaya I.N., Mackow E.R. Pathogenic and nonpathogenic hantaviruses differentially regulate endothelial cell responses. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:13837-13842.
33. Godoy P., Marsac D., Stefas E., Ferrer P., Tischler N.D., Pino K., Ramdohr P., Vial P., Valenzuela P.D., Ferres M., et al. Andes virus antigens are shed in urine of patients with acute hantavirus cardiopulmonary syndrome. Journal of Virology 2009, 83:5046-5055.
34. Goldsmith C.S., Elliott L.H., Peters C.J., Zaki S.R. Ultrastructural characteristics of Sin Nombre virus, causative agent of hantavirus pulmonary syndrome. Archives of Virology 1995, 140:2107-2122.
35. Gorbunova E., Gavrilovskaya I.N., Mackow E.R. Pathogenic hantaviruses Andes virus and Hantaan virus induce adherens junction disassembly by directing vascular endothelial cadherin internalization in human endothelial cells. Journal of Virology 2010, 84:7405-7411.
36. Gorbunova E.E., Gavrilovskaya I.N., Pepini T., Mackow E.R. VEGFR2 and Src kinase inhibitors suppress Andes virus-induced endothelial cell permeability. Journal of Virology 2011, 85:2296-2303.
37. Habjan M., Andersson I., Klingstrom J., Schumann M., Martin A., Zimmermann P., Wagner V., Pichlmair A., Schneider U., Muhlberger E., et al. Processing of genome 5' termini as a strategy of negative-strand RNA viruses to avoid RIG-I-dependent interferon induction. PLoS One 2008, 3:e2032.
38. Hall P.R., Hjelle B., Brown D.C., Ye C., Bondu-Hawkins V., Kilpatrick K.A., Larson R.S. Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade. Antimicrobial Agents and Chemotherapy 2008, 52:2079-2088.
39. Hall P.R., Hjelle B., Njus H., Ye C., Bondu-Hawkins V., Brown D.C., Kilpatrick K.A., Larson R.S. Phage display selection of cyclic peptides that inhibit Andes virus infection. Journal of Virology 2009, 83:8965-8969.
40. Hallin G.W., Simpson S.Q., Crowell R.E., James D.S., Koster F.T., Mertz G.J., Levy H. Cardiopulmonary manifestations of hantavirus pulmonary syndrome. Critical Care Medicine 1996, 24:252-258.
41. Hammerbeck C.D., Hooper J.W. T cells are not required for pathogenesis in the Syrian Hamster model of Hantavirus pulmonary syndrome. Journal of Virology 2011.
42. Handke W., Oelschlegel R., Franke R., Kruger D.H., Rang A. Hantaan virus triggers TLR3-dependent innate immune responses. Journal of Immunology 2009, 182:2849-2858.
43. Hayasaka D., Maeda K., Ennis F.A., Terajima M. Increased permeability of human endothelial cell line EA.hy926 induced by hantavirus-specific cytotoxic T lymphocytes. Virus Research 2007, 123:120-127.
44. Hepojoki J., Strandin T., Vaheri A., Lankinen H. Interactions and oligomerization of hantavirus glycoproteins. Journal of Virology 2010, 84:227-242.
45. Hjelle B., Goade D., Torrez-Martinez N., Lang-Williams M., Kim J., Harris R.L., Rawlings J.A. Hantavirus pulmonary syndrome, renal insufficiency, and myositis associated with infection by Bayou hantavirus. Clinical Infectious Diseases 1996, 23:495-500.
46. Hjelle B., Lee S.W., Song W., Torrez-Martinez N., Song J.W., Yanagihara R., Gavrilovskaya I., Mackow E.R. Molecular linkage of hantavirus pulmonary syndrome to the white-footed mouse, Peromyscus leucopus: genetic characterization of the M genome of New York virus. Journal of Virology 1995, 69:8137-8141.
47. Holmes R., Boccanera R., Figueiredo L.T., Mancano S.R., Pane C. Seroprevalence of human hantavirus infection in the Ribeirao Preto region of Sao Paulo State, Brazil. Emerging Infectious Disease 2000, 6:560-561.
48. Hooper J.W., Custer D.M., Smith J., Wahl-Jensen V. Hantaan/Andes virus DNA vaccine elicits a broadly cross-reactive neutralizing antibody response in nonhuman primates. Virology 2006, 347:208-216.
49. Hooper J.W., Ferro A.M., Wahl-Jensen V. Immune serum produced by DNA vaccination protects hamsters against lethal respiratory challenge with Andes virus. Journal of Virology 2008, 82:1332-1338.
50. Hooper J.W., Larsen T., Custer D.M., Schmaljohn C.S. A lethal disease model for hantavirus pulmonary syndrome. Virology 2001, 289:6-14.
51. Hutchinson K.L., Peters C.J., Nichol S.T. Sin Nombre virus mRNA synthesis. Virology 1996, 224:139-149.
52. Jenison S., Yamada T., Morris C., Anderson B., Torrez-Martinez N., Keller N., Hjelle B. Characterization of human antibody responses to four corners hantavirus infections among patients with hantavirus pulmonary syndrome. Journal of Virology 1994, 68:3000-3006.
53. Jiang H., Wang P.Z., Zhang Y., Xu Z., Sun L., Wang L.M., Huang C.X., Lian J.Q., Jia Z.S., Li Z.D., et al. Hantaan virus induces toll-like receptor 4 expression, leading to enhanced production of beta interferon, interleukin-6 and tumor necrosis factor-alpha. Virology 2008, 380:52-59.
54. Johnson A.M., Bowen M.D., Ksiazek T.G., Williams R.J., Bryan R.T., Mills J.N., Peters C.J., Nichol S.T. Laguna Negra virus associated with HPS in western Paraguay and Bolivia. Virology 1997, 238:115-127.
55. Johnson A.M., de Souza L.T., Ferreira I.B., Pereira L.E., Ksiazek T.G., Rollin P.E., Peters C.J., Nichol S.T. Genetic investigation of novel hantaviruses causing fatal HPS in Brazil. Journal of Medical Virology 1999, 59:527-535.
56. Jonsson C.B., Hooper J., Mertz G. Treatment of hantavirus pulmonary syndrome. Antiviral Research 2008, 78:162-169.
57. Kamrud K.I., Schmaljohn C.S. Expression strategy of the M genome segment of Hantaan virus. Virus Research 1994, 31:109-121.
58. Ketai L.H., Williamson M.R., Telepak R.J., Levy H., Koster F.T., Nolte K.B., Allen S.E. Hantavirus pulmonary syndrome: radiographic findings in 16 patients. Radiology 1994, 191:665-668.
59. Khaiboullina S.F., St Jeor S.C. Hantavirus immunology. Viral Immunology 2002, 15:609-625.
60. Khan A.S., Gaviria M., Rollin P.E., Hlady W.G., Ksiazek T.G., Armstrong L.R., Greenman R., Ravkov E., Kolber M., Anapol H., et al. Hantavirus pulmonary syndrome in Florida: association with the newly identified Black Creek Canal virus. The American Journal of Medicine 1996, 100:46-48.
61. Khan A.S., Khabbaz R.F., Armstrong L.R., Holman R.C., Bauer S.P., Graber J., Strine T., Miller G., Reef S., Tappero J., et al. Hantavirus pulmonary syndrome: the first 100 US cases. The Journal of Infectious Diseases 1996, 173:1297-1303.
62. Khan A.S., Spiropoulou C.F., Morzunov S., Zaki S.R., Kohn M.A., Nawas S.R., McFarland L., Nichol S.T. Fatal illness associated with a new hantavirus in Louisiana. Journal of Medical Virology 1995, 46:281-286.
63. Kilpatrick E.D., Terajima M., Koster F.T., Catalina M.D., Cruz J., Ennis F.A. Role of specific CD8+ T cells in the severity of a fulminant zoonotic viral hemorrhagic fever, hantavirus pulmonary syndrome. Journal of Immunology 2004, 172:3297-3304.
64. Kim I.W., Hwang J.Y., Kim S.K., Kim J.K., Park H.S. Interferon-stimulated genes response in endothelial cells following Hantaan virus infection. Journal of Korean Medical Science 2007, 22:987-992.
65. Klein S.L., Marks M.A., Li W., Glass G.E., Fang L.Q., Ma J.Q., Cao W.C. Sex differences in the incidence and case fatality rates from hemorrhagic Fever with renal syndrome in china, 2004-2008. Clinical Infectious Diseases 2011, 52:1414-1421.
66. Ksiazek T.G., Nichol S.T., Mills J.N., Groves M.G., Wozniak A., McAdams S., Monroe M.C., Johnson A.M., Martin M.L., Peters C.J., et al. Isolation, genetic diversity, and geographic distribution of Bayou virus (Bunyaviridae: hantavirus). American Journal of Tropical Medicine and Hygiene 1997, 57:445-448.
67. Ksiazek T.G., Peters C.J., Rollin P.E., Zaki S., Nichol S., Spiropoulou C., Morzunov S., Feldmann H., Sanchez A., Khan A.S., et al. Identification of a new North American hantavirus that causes acute pulmonary insufficiency. American Journal of Tropical Medicine and Hygiene 1995, 52:117-123.
68. Lampugnani M.G., Dejana E. The control of endothelial cell functions by adherens junctions. Novartis Foundation Symposium 2007, 283:4-13. discussion 13-17, 238-241.
69. Lampugnani M.G., Orsenigo F., Gagliani M.C., Tacchetti C., Dejana E. Vascular endothelial cadherin controls VEGFR-2 internalization and signaling from intracellular compartments. Journal of Cell Biology 2006, 174:593-604.
70. Larson R.S., Brown D.C., Ye C., Hjelle B. Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor. Journal of Virology 2005, 79:7319-7326.
71. Lazaro M.E., Cantoni G.E., Calanni L.M., Resa A.J., Herrero E.R., Iacono M.A., Enria D.A., Gonzalez Cappa S.M. Clusters of hantavirus infection, southern Argentina. Emerging Infectious Diseases 2007, 13:104-110.
72. Levine J.R., Prescott J., Brown K.S., Best S.M., Ebihara H., Feldmann H. Antagonism of type I interferon responses by new world hantaviruses. Journal of Virology 2010, 84:11790-11801.
73. Levis S., Morzunov S.P., Rowe J.E., Enria D., Pini N., Calderon G., Sabattini M., St Jeor S.C. Genetic diversity and epidemiology of hantaviruses in Argentina. The Journal of Infectious Diseases 1998, 177:529-538.
74. Levis S., Rowe J.E., Morzunov S., Enria D.A., St Jeor S. New hantaviruses causing hantavirus pulmonary syndrome in central Argentina. The Lancet 1997, 349:998-999.
75. Limongi J.E., da Costa F.C., Pinto R.M., de Oliveira R.C., Bragagnolo C., Lemos E.R., de Paula M.B., Pajuaba Neto A.A., Ferreira M.S. Cross-sectional survey of hantavirus infection, Brazil. Emerging Infectious Diseases 2009, 15:1981-1983.
76. Lopez N., Padula P., Rossi C., Lazaro M.E., Franze-Fernandez M.T. Genetic identification of a new hantavirus causing severe pulmonary syndrome in Argentina. Virology 1996, 220:223-226.
77. Mackow E.R., Gavrilovskaya I.N. Cellular receptors and hantavirus pathogenesis. Current Topics in Microbiology and Immunology 2001, 256:91-115.
78. Mackow E.R., Gavrilovskaya I.N. Hantavirus regulation of endothelial cell functions. Thrombosis and Haemostasis 2009, 102:1030-1041.
79. MacNeil A., Comer J.A., Ksiazek T.G., Rollin P.E. Sin Nombre virus-specific immunoglobulin M and G kinetics in hantavirus pulmonary syndrome and the role played by serologic responses in predicting disease outcome. The Journal of Infectious Diseases 2010, 202:242-246.
80. Macneil A., Ksiazek T.G., Rollin P.E. Hantavirus pulmonary syndrome United States, 1993-2009. Emerging Infectious Diseases 2011, 17:1195-1201.
81. Manigold T., Mori A., Graumann R., Llop E., Simon V., Ferres M., Valdivieso F., Castillo C., Hjelle B., Vial P. Highly differentiated, resting gn-specific memory CD8+ T cells persist years after infection by andes hantavirus. PLoS Pathogens 2010, 6:e1000779.
82. Markotic A., Hensley L., Daddario K., Spik K., Anderson K., Schmaljohn C. Pathogenic hantaviruses elicit different immunoreactions in THP-1 cells and primary monocytes and induce differentiation of human monocytes to dendritic-like cells. Collegium Antropologicum 2007, 31:1159-1167.
83. Marsac D., Garcia S., Fournet A., Aguirre A., Pino K., Ferres M., Kalergis A.M., Lopez-Lastra M., Veas F. Infection of human monocyte-derived dendritic cells by ANDES Hantavirus enhances pro-inflammatory state, the secretion of active MMP-9 and indirectly enhances endothelial permeability. Virology Journal 2011, 8:223.
84. Martin M.L., Lindsey-Regnery H., Sasso D.R., McCormick J.B., Palmer E. Distinction between Bunyaviridae genera by surface structure and comparison with Hantaan virus using negative stain electron microscopy. Archives of Virology 1985, 86:17-28.
85. Martinez V.P., Bellomo C., San Juan J., Pinna D., Forlenza R., Elder M., Padula P.J. Person-to-person transmission of Andes virus. Emerging Infectious Diseases 2005, 11:1848-1853.
86. Martinez V.P., Bellomo C.M., Cacace M.L., Suarez P., Bogni L., Padula P.J. Hantavirus pulmonary syndrome in Argentina, 1995-2008. Emerging Infectious Diseases 2010, 16:1853-1860.
87. Matheus S., Djossou F., Moua D., Bourbigot A.M., Hommel D., Lacoste V., Dussart P., Lavergne A. Hantavirus pulmonary syndrome, French Guiana. Emerging Infectious Diseases 2010, 16:739-741.
88. Matthys V.S., Gorbunova E.E., Gavrilovskaya I.N., Mackow E.R. Andes virus recognition of human and Syrian hamster beta3 integrins is determined by an L33P substitution in the PSI domain. Journal of Virology 2010, 84:352-360.
89. McElroy A.K., Bray M., Reed D.S., Schmaljohn C.S. Andes virus infection of cynomolgus macaques. The Journal of Infectious Diseases 2002, 186:1706-1712.
90. Mendes W.S., da Silva A.A., Aragao L.F., Aragao N.J., Raposo Mde L., Elkhoury M.R., Suzuky A., Ferreira I.B., de Sousa L.T., Pannuti C.S. Hantavirus infection in Anajatuba, Maranhao, Brazil. Emerging Infectious Diseases 2004, 10:1496-1498.
91. Mendes W.S., da Silva A.A., Neiva R.F., Costa N.M., de Assis M.S., Vidigal P.M., da G.L.L.M., da Rosa E.S., de A.M.D.B., de B.S.D., et al. Serologic survey of hantavirus infection, Brazilian Amazon. Emerging Infectious Diseases 2010, 16:889-891.
92. Mertz G.J., Miedzinski L., Goade D., Pavia A.T., Hjelle B., Hansbarger C.O., Levy H., Koster F.T., Baum K., Lindemulder A., et al. Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America. Clinical Infectious Diseases 2004, 39:1307-1313.
93. Milazzo M.L., Eyzaguirre E.J., Molina C.P., Fulhorst C.F. Maporal viral infection in the Syrian golden hamster: a model of hantavirus pulmonary syndrome. The Journal of Infectious Diseases 2002, 186:1390-1395.
94. Mir M.A., Brown B., Hjelle B., Duran W.A., Panganiban A.T. Hantavirus N protein exhibits genus-specific recognition of the viral RNA panhandle. Journal of Virology 2006, 80:11283-11292.
95. Mir M.A., Duran W.A., Hjelle B.L., Ye C., Panganiban A.T. Storage of cellular 5' mRNA caps in P bodies for viral cap-snatching. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:19294-19299.
96. Mir M.A., Panganiban A.T. Trimeric hantavirus nucleocapsid protein binds specifically to the viral RNA panhandle. Journal of Virology 2004, 78:8281-8288.
97. Mir M.A., Panganiban A.T. The hantavirus nucleocapsid protein recognizes specific features of the viral RNA panhandle and is altered in conformation upon RNA binding. Journal of Virology 2005, 79:1824-1835.
98. Mir M.A., Panganiban A.T. Characterization of the RNA chaperone activity of hantavirus nucleocapsid protein. Journal of Virology 2006, 80:6276-6285.
99. Mir M.A., Panganiban A.T. A protein that replaces the entire cellular eIF4F complex. EMBO Journal 2008, 27:3129-3139.
100. MMWR Outbreak of acute illness-Southwestern United States, 1993. MMWR 1993, 42:421-424.
101. MMWR Notes from the field: hantavirus pulmonary syndrome-maine, April 2011. MMWR Morbidity and Mortality Weekly Report 2011, 60:786.
102. Mori M., Rothman A.L., Kurane I., Montoya J.M., Nolte K.B., Norman J.E., Waite D.C., Koster F.T., Ennis F.A. High levels of cytokine-producing cells in the lung tissues of patients with fatal hantavirus pulmonary syndrome. The Journal of Infectious Diseases 1999, 179:295-302.
103. Morzunov S.P., Feldmann H., Spiropoulou C.F., Semenova V.A., Rollin P.E., Ksiazek T.G., Peters C.J., Nichol S.T. A newly recognized virus associated with a fatal case of hantavirus pulmonary syndrome in Louisiana. Journal of Virology 1995, 69:1980-1983.
104. Morzunov S.P., Rowe J.E., Ksiazek T.G., Peters C.J., St Jeor S.C., Nichol S.T. Genetic analysis of the diversity and origin of hantaviruses in Peromyscus leucopus mice in North America. Journal of Virology 1998, 72:57-64.
105. Nichol S.T., Spiropoulou C.F., Morzunov S., Rollin P.E., Ksiazek T.G., Feldmann H., Sanchez A., Childs J., Zaki S., Peters C.J. Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science 1993, 262:914-917.
106. Nolte K.B., Feddersen R.M., Foucar K., Zaki S.R., Koster F.T., Madar D., Merlin T.L., McFeeley P.J., Umland E.T., Zumwalt R.E. Hantavirus pulmonary syndrome in the United States: a pathological description of a disease caused by a new agent. Human Pathology 1995, 26:110-120.
107. Ogino M., Yoshimatsu K., Ebihara H., Araki K., Lee B.H., Okumura M., Arikawa J. Cell fusion activities of Hantaan virus envelope glycoproteins. Journal of Virology 2004, 78:10776-10782.
108. Padula P., Martinez V.P., Bellomo C., Maidana S., San Juan J., Tagliaferri P., Bargardi S., Vazquez C., Colucci N., Estevez J., et al. Pathogenic hantaviruses, northeastern Argentina and eastern Paraguay. Emerging Infectious Diseases 2007, 13:1211-1214.
109. Padula P.J., Colavecchia S.B., Martinez V.P., Gonzalez Della Valle M.O., Edelstein A., Miguel S.D., Russi J., Riquelme J.M., Colucci N., Almiron M., et al. Genetic diversity, distribution, and serological features of hantavirus infection in five countries in South America. Journal of Clinical Microbiology 2000, 38:3029-3035.
110. Padula P.J., Edelstein A., Miguel S.D., Lopez N.M., Rossi C.M., Rabinovich R.D. Hantavirus pulmonary syndrome outbreak in Argentina: molecular evidence for person-to-person transmission of Andes virus. Virology 1998, 241:323-330.
111. Pergam S.A., Schmidt D.W., Nofchissey R.A., Hunt W.C., Harford A.H., Goade D.E. Potential renal sequelae in survivors of hantavirus cardiopulmonary syndrome. American Journal of Tropical Medicine and Hygiene 2009, 80:279-285.
112. Pettersson M.L. Synthesis, assembly and intracellular transport of Bunyaviridae membrane proteins. The Bunyaviridae 1996, 159-188. Plenum Press, New York. R.M. Elliott (Ed.).
113. Plyusnin A. Genetics of hantaviruses: implications to taxonomy. Archives of Virology 2002, 147:665-682.
114. Prescott J.B., Hall P.R., Bondu-Hawkins V.S., Ye C., Hjelle B. Early innate immune responses to Sin Nombre hantavirus occur independently of IFN regulatory factor 3, characterized pattern recognition receptors, and viral entry. Journal of Immunology 2007, 179:1796-1802.
115. Ravkov E.V., Compans R.W. Hantavirus nucleocapsid protein is expressed as a membrane-associated protein in the perinuclear region. Journal of Virology 2001, 75:1808-1815.
116. Ravkov E.V., Nichol S.T., Compans R.W. Polarized entry and release in epithelial cells of Black Creek Canal virus, a New World hantavirus,. Journal of Virology 1997, 71:1147-1154.
117. Ravkov E.V, Nichol S.T., Peters C.J., Compans R.W. Role of actin microfilaments in Black Creek Canal virus morphogenesis. Journal of Virology 1998, 72:2865-2870.
118. Ravkov E.V., Rollin P.E., Ksiazek T.G., Peters C.J., Nichol S.T. Genetic and serologic analysis of Black Creek Canal virus and its association with human disease and Sigmodon hispidus infection. Virology 1995, 210:482-489.
119. Reguera J., Weber F., Cusack S. Bunyaviridae RNA polymerases (l-protein) have an N-terminal, influenza-like endonuclease domain, essential for viral cap-dependent transcription. PLoS Pathogens 2010, 6.
120. Rhodes L.V., Huang C., Sanchez A.J., Nichol S.T., Zaki S.R., Ksiazek T.G., Humphreys J.G., Freeman J.J., Knecht K.R. Hantavirus pulmonary syndrome associated with Monongahela virus, Pennsylvania. Emerging Infectious Diseases 2000, 6:616-621.
121. Riquelme R., Riquelme M., Torres A., Rioseco M.L., Vergara J.A., Scholz L., Carriel A. Hantavirus pulmonary syndrome, southern Chile. Emerging Infectious Diseases 2003, 9:1438-1443.
122. Rodriguez L.L., Owens J.H., Peters C.J., Nichol S.T. Genetic reassortment among viruses causing hantavirus pulmonary syndrome. Virology 1998, 242:99-106.
123. Rollin P.E., Ksiazek T.G., Elliott L.H., Ravkov E.V., Martin M.L., Morzunov S., Livingstone W., Monroe M., Glass G., Ruo S., et al. Isolation of black creek canal virus, a new hantavirus from Sigmodon hispidus in Florida,. Journal of Medical Virology 1995, 46:35-39.
124. Rowe R.K, Pekosz A. Bidirectional virus secretion and nonciliated cell tropism following Andes virus infection of primary airway epithelial cell cultures. Journal of Virology 2006, 80:1087-1097.
125. Safronetz D., Haddock E., Feldmann F., Ebihara H., Feldmann H. In vitro and in vivo activity of ribavirin against Andes virus infection. PLoS One 2011, 6:e23560.
126. Safronetz D., Hegde N.R., Ebihara H., Denton M., Kobinger G.P., St Jeor S., Feldmann H., Johnson D.C. Adenovirus vectors expressing hantavirus proteins protect hamsters against lethal challenge with andes virus. Journal of Virology 2009, 83:7285-7295.
127. Schmaljohn C.S. Nucleotide sequence of the L genome segment of Hantaan virus. Nucleic Acids Research 1990, 18:6728.
128. Schmaljohn C.S., Dalrymple J.M. Analysis of Hantaan virus RNA: evidence for a new genus of bunyaviridae. Virology 1983, 131:482-491.
129. Schmaljohn C.S., Hasty S.E., Rasmussen L., Dalrymple J.M. Hantaan virus replication: effects of monensin, tunicamycin and endoglycosidases on the structural glycoproteins. Journal of General Virology 1986, 67(Pt 4):707-717.
130. Schmaljohn C.S., Jennings G.B., Hay J., Dalrymple J.M. Coding strategy of the S genome segment of Hantaan virus. Virology 1986, 155:633-643.
131. Schmaljohn C.S., Schmaljohn A.L., Dalrymple J.M. Hantaan virus M RNA: coding strategy, nucleotide sequence, and gene order. Virology 1987, 157:31-39.
132. Schwarcz S.K., Shefer A.M., Zaki S.R. Retrospective diagnosis of a fatal case of the hantavirus pulmonary syndrome, 1980. Western Journal of Medicine 1996, 164:348-350.
133. Shrivastava-Ranjan P., Rollin P.E., Spiropoulou C.F. Andes virus disrupts the endothelial cell barrier by induction of vascular endothelial growth factor and downregulation of VE-cadherin. Journal of Virology 2010, 84:11227-11234.
134. Song J.W., Baek L.J., Gajdusek D.C., Yanagihara R., Gavrilovskaya I., Luft B.J., Mackow E.R., Hjelle B. Isolation of pathogenic hantavirus from white-footed mouse (Peromyscus leucopus). The Lancet 1994, 344:1637.
135. Spiropoulou C.F. Hantavirus maturation. Current Topics in Microbiology and Immunology 2001, 256:33-46.
136. Spiropoulou C.F., Albarino C.G., Ksiazek T.G., Rollin P.E. Andes and Prospect Hill hantaviruses differ in early induction of interferon although both can downregulate interferon signaling. Journal of Virology 2007, 81:2769-2776.
137. Spiropoulou C.F., Goldsmith C.S., Shoemaker T.R., Peters C.J., Compans R.W. Sin Nombre virus glycoprotein trafficking. Virology 2003, 308:48-63.
138. Spiropoulou C.F., Morzunov S., Feldmann H., Sanchez A., Peters C.J., Nichol S.T. Genome structure and variability of a virus causing hantavirus pulmonary syndrome. Virology 1994, 200:715-723.
139. Srikiatkhachorn A., Ajariyakhajorn C., Endy T.P., Kalayanarooj S., Libraty D.H., Green S., Ennis F.A., Rothman A.L. Virus-induced decline in soluble vascular endothelial growth receptor 2 is associated with plasma leakage in dengue hemorrhagic Fever. Journal of Virology 2007, 81:1592-1600.
140. Stephen C., Johnson M., Bell A. First reported cases of hantavirus pulmonary syndrome in Canada. Canada Communicable Disease Report 1994, 20:121-125.
141. Strandin T., Hepojoki J., Wang H., Vaheri A., Lankinen H. The cytoplasmic tail of hantavirus Gn glycoprotein interacts with RNA. Virology 2011.
142. Sundstrom J.B., McMullan L.K., Spiropoulou C.F., Hooper W.C., Ansari A.A., Peters C.J., Rollin P.E. Hantavirus infection induces the expression of RANTES and IP-10 without causing increased permeability in human lung microvascular endothelial cells. Journal of Virology 2001, 75:6070-6085.
143. Taddei A., Giampietro C., Conti A., Orsenigo F., Breviario F., Pirazzoli V., Potente M., Daly C., Dimmeler S., Dejana E. Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5. Nature Cell Biology 2008, 10:923-934.
144. Tager Frey M., Vial P.C., Castillo C.H., Godoy P.M., Hjelle B., Ferres M.G. Hantavirus prevalence in the IX Region of Chile. Emerging Infectious Diseases 2003, 9:827-832.
145. Takeuchi O., Akira S. Innate immunity to virus infection. Immunological Reviews 2009, 227:75-86.
146. Tao H., Xia S.M., Chan Z.Y., Song G., Yanagihara R. Morphology and morphogenesis of viruses of hemorrhagic fever with renal syndrome II. Inclusion bodies-ultrastructural markers of hantavirus-infected cells. Intervirology 1987, 27:45-52.
147. Terajima M., Hayasaka D., Maeda K., Ennis F.A. Immunopathogenesis of hantavirus pulmonary syndrome and hemorrhagic fever with renal syndrome: do CD8+ T cells trigger capillary leakage in viral hemorrhagic fevers?. Immunology Letters 2007, 113:117-120.
148. Terajima M., Hendershot J.D., Kariwa H., Koster F.T., Hjelle B., Goade D., DeFronzo M.C., Ennis F.A. High levels of viremia in patients with the Hantavirus pulmonary syndrome. The Journal of Infectious Diseases 1999, 180:2030-2034.
149. Terajima M., Van Epps H.L., Li D., Leporati A.M., Juhlin S.E., Mustonen J., Vaheri A., Ennis F.A. Generation of recombinant vaccinia viruses expressing Puumala virus proteins and use in isolating cytotoxic T cells specific for Puumala virus. Virus Research 2002, 84:67-77.
150. Tischler N.D., Gonzalez A., Perez-Acle T., Rosemblatt M., Valenzuela P.D. Hantavirus Gc glycoprotein: evidence for a class II fusion protein. Journal of General Virology 2005, 86:2937-2947.
151. Toro J., Vega J.D., Khan A.S., Mills J.N., Padula P., Terry W., Yadon Z., Valderrama R., Ellis B.A., Pavletic C., et al. An outbreak of hantavirus pulmonary syndrome, Chile, 1997. Emerging Infectious Diseases 1998, 4:687-694.
152. Torrez-Martinez N., Bharadwaj M., Goade D., Delury J., Moran P., Hicks B., Nix B., Davis J.L., Hjelle B. Bayou virus-associated hantavirus pulmonary syndrome in Eastern Texas: identification of the rice rat, Oryzomys palustris, as reservoir host. Emerging Infectious Diseases 1998, 4:105-111.
153. Travassos da Rosa E.S., Sampaio de Lemos E.R., de Almeida Medeiros D.B., Simith D.B., de Souza Pereira A., Elkhoury M.R., Mendes W.S., Vidigal J.R., de Oliveira R.C., D'Andrea P.S., et al. Hantaviruses and hantavirus pulmonary syndrome, Maranhao, Brazil. Emerging Infectious Diseases 2010, 16:1952-1955.
154. Valdivieso F., Vial P., Ferres M., Ye C., Goade D., Cuiza A., Hjelle B. Neutralizing antibodies in survivors of Sin Nombre and Andes hantavirus infection. Emerging Infectious Diseases 2006, 12:166-168.
155. Van Epps H.L., Schmaljohn C.S., Ennis F.A. Human memory cytotoxic T-lymphocyte (CTL) responses to Hantaan virus infection: identification of virus-specific and cross-reactive CD8(+) CTL epitopes on nucleocapsid protein. Journal of Virology 1999, 73:5301-5308.
156. Van Epps H.L., Terajima M., Mustonen J., Arstila T.P., Corey E.A., Vaheri A., Ennis F.A. Long-lived memory T lymphocyte responses after hantavirus infection. Journal of Experimental Medicine 2002, 196:579-588.
157. Vial P.A., Valdivieso F., Mertz G., Castillo C., Belmar E., Delgado I., Tapia M., Ferres M. Incubation period of hantavirus cardiopulmonary syndrome. Emerging Infectious Diseases 2006, 12:1271-1273.
158. Vincent M.J., Quiroz E., Gracia F., Sanchez A.J., Ksiazek T.G., Kitsutani P.T., Ruedas L.A., Tinnin D.S., Caceres L., Garcia A., et al. Hantavirus pulmonary syndrome in Panama: identification of novel hantaviruses and their likely reservoirs. Virology 2000, 277:14-19.
159. Vitek C.R., Breiman R.F., Ksiazek T.G., Rollin P.E., McLaughlin J.C., Umland E.T., Nolte K.B., Loera A., Sewell C.M., Peters C.J. Evidence against person-to-person transmission of hantavirus to health care workers. Clinical Infectious Diseases 1996, 22:824-826.
160. Wahl-Jensen V., Chapman J., Asher L., Fisher R., Zimmerman M., Larsen T., Hooper J.W. Temporal analysis of Andes virus and Sin Nombre virus infections of Syrian hamsters. Journal of Virology 2007, 81:7449-7462.
161. Wells R.M., Sosa Estani S., Yadon Z.E., Enria D., Padula P., Pini N., Gonzalez Della Valle M., Mills J.N., Peters C.J. Seroprevalence of antibodies to hantavirus in health care workers and other residents of southern Argentina. Clinical Infectious Diseases 1998, 27:895-896.
162. Wells R.M., Young J., Williams R.J., Armstrong L.R., Busico K., Khan A.S., Ksiazek T.G., Rollin P.E., Zaki S.R., Nichol S.T., et al. Hantavirus transmission in the United States. Emerging Infectious Diseases 1997, 3:361-365.
163. Williams R.J., Bryan R.T., Mills J.N., Palma R.E., Vera I., De Velasquez F., Baez E., Schmidt W.E., Figueroa R.E., Peters C.J., et al. An outbreak of hantavirus pulmonary syndrome in western Paraguay. American Journal of Tropical Medicine and Hygiene 1997, 57:274-282.
164. Wilson C., Hjelle B., Jenison S. Probable hantavirus pulmonary syndrome that occurred in New Mexico in 1975. Annals of Internal Medicine 1994, 120:813.
165. Xiao K., Allison D.F., Kottke M.D., Summers S., Sorescu G.P., Faundez V., Kowalczyk A.P. Mechanisms of VE-cadherin processing and degradation in microvascular endothelial cells. Journal of Biological Chemistry 2003, 278:19199-19208.
166. Xiao R., Yang S., Koster F., Ye C., Stidley C., Hjelle B. Sin Nombre viral RNA load in patients with hantavirus cardiopulmonary syndrome. The Journal of Infectious Diseases 2006, 194:1403-1409.
167. Zaki S.R., Albers R.C., Greer P.W., Coffield L.M., Armstrong L.R., Khan A.S., Khabbaz R., Peters C.J. Retrospective diagnosis of a 1983 case of fatal hantavirus pulmonary syndrome. The Lancet 1994, 343:1037-1038.
168. Zaki S.R., Greer P.W., Coffield L.M., Goldsmith C.S., Nolte K.B., Foucar K., Feddersen R.M., Zumwalt R.E., Miller G.L., Khan A.S., et al. Hantavirus pulmonary syndrome Pathogenesis of an emerging infectious disease. The American Journal of Pathology 1995, 146:552-579.
169. Zaki S.R., Khan A.S., Goodman R.A., Armstrong L.R., Greer P.W., Coffield L.M., Ksiazek T.G., Rollin P.E., Peters C.J., Khabbaz R.F. Retrospective diagnosis of hantavirus pulmonary syndrome, 1978-1993: implications for emerging infectious diseases. Archives of Pathology & Laboratory Medicine 1996, 120:134-139.
170. Zeitz P.S., Graber J.M., Voorhees R.A., Kioski C., Shands L.A., Ksiazek T.G., Jenison S., Khabbaz R.F. Assessment of occupational risk for hantavirus infection in Arizona and New Mexico. Journal of Occupational and Environmental Medicine/American College of Occupational and Environmental Medicine 1997, 39:463-467.
171. Zivcec M., Safronetz D., Haddock E., Feldmann H., Ebihara H. Validation of assays to monitor immune responses in the Syrian golden hamster (Mesocricetus auratus). Journal of Immunological Methods 2011, 368:24-35.